Topic: Janssen

British Telecom (BT) announced plans to cut 55,000 jobs by 2030, with approximately 10,000 positions expected to be replaced by artificial intelligence. CEO Philip Janssen stated that AI tools like GPT are now capable of handling customer service tasks traditionally performed by humans. This move is part of a broader trend in the tech industry to reduce "bloated" staff as interest rates rise and free money disappears.

Public perception of COVID-19 vaccines has evolved into a form of "brand shopping," with Pfizer often viewed as the premium option despite similar technology in the Moderna shot. Johnson & Johnson has successfully marketed its Janssen vaccine with the "one and done" slogan, appealing to those wanting to avoid multiple appointments. Financial analysis shows the U.S. government pays significantly different rates per dose: $30 for Moderna, $19.50 for Pfizer, and $10 for Johnson & Johnson.

The upcoming release of the DSM-5 introduces "Psychosis Risk Syndrome" (PRS), which the hosts criticize as a way to medicate people before they develop mental illness. They discuss the drug Risperdal (Risperidone) and its use in treating various disorders. John C. Dvorak shares a historical anecdote about lobotomies being marketed as a medical miracle to illustrate the dangers of popular medical trends.